★ Free Shipping On All Orders•✓ Third-Party Tested & Verified Purity•✓ Trusted By Researchers Nationwide•★ Same-Day Dispatch On All Orders•

★ Free Shipping On All Orders•✓ Third-Party Tested & Verified Purity•✓ Trusted By Researchers Nationwide•★ Same-Day Dispatch On All Orders•

SHRED Bundle — Tesamorelin 10mg + Reta 20mg

$195.00

Power duo for metabolic and body composition research. Combines a GHRH analog with a triple-receptor agonist for multi-pathway fat metabolism studies.

≥99% HPLC Purity

Same-Day Dispatch

COA on Every Batch

Description

What’s Inside

  • Tesamorelin 10mg — Synthetic GHRH analog that stimulates pituitary GH secretion, extensively studied for visceral adipose tissue reduction
  • Retatrutide 20mg — Novel triple-agonist targeting GIP, GLP-1, and glucagon receptors simultaneously for comprehensive metabolic research

Why This Bundle?

SHRED+ combines two powerful metabolic research compounds that target different but synergistic pathways. Tesamorelin drives GH-mediated lipolysis while Retatrutide activates three incretin/glucagon pathways — making this bundle ideal for advanced body composition and metabolic research protocols.

Specifications

  • Purity: ≥99.0% each (HPLC verified)
  • Form: Lyophilized powder
  • Storage: Store at -20°C, protect from light
  • Third-party lab tested with COA available on request

For research use only. Not for human consumption.

Reviews

There are no reviews yet.

Be the first to review “SHRED Bundle — Tesamorelin 10mg + Reta 20mg”

Your email address will not be published. Required fields are marked *

You May Also Like

Price range: $44.00 through $200.00

Verification Required

Axion Ageless sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use.

Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.